通过远程医疗的第一季度药物流产:一个回顾性队列研究
Leonardo Cely-Andrade1, Luis Carlos Enríquez-Santander1, Karen Cárdenas-Garzón1
1Profamilia, Bogotá, Colombia.
Public health in practice (Oxford, England)
|September 23, 2024
概括
哥伦比亚的远程医疗辅助药物堕胎 (MAB) 是第一季度堕胎的安全有效选择. 该计划扩大了服务不足的人群获得护理的机会,证明了远程医疗在生殖健康方面的潜力.
科学领域:
- 生殖健康 生殖健康
- 远程医疗远程医疗
- 公共卫生 公共卫生
背景情况:
- 哥伦比亚对堕胎的非刑事化和COVID-19的流行病促使哥伦比亚实施了远程医疗辅助的第一季度药物堕胎 (MAB).
- 该倡议旨在减少获取不平等,促进性和生殖权利.
- 该计划提供了一个改善医疗保健可访问性的机会.
研究的目的:
- 描述使用远程医疗MAB服务的个人的社会人口统计和临床特征.
- 评估本MAB计划的有效性和安全性.
主要方法:
- 一项回顾性队列研究分析了Profamilia远程医疗堕胎服务的3073名用户 (2021年8月至2022年8月) 的数据.
- 对社会人口统计和临床数据进行了描述性分析,根据随访状态对结果进行了比较.
- 通过没有手术的完整堕胎率来衡量有效性;通过并发症发生率来评估安全性.
主要成果:
- 大多数使用者怀孕8周以下 (88.3%),来自低社会经济阶层 (84.8%),并隶属于补贴医疗保健 (87.6%).
- 使用药物实现了高完全堕胎率 (94.9%),并发症发生率低 (0.3%).
结论:
- 远程医疗辅助的第一季度MAB是拉丁美洲背景下有效和安全的生殖保健选择.
- 远程医疗对于扩大安全堕胎的机会至关重要,特别是在经济和教育上处于不利地位的群体中.
- 需要进一步关注,以加强农村和边缘化人口的获取.
相关概念视频
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Drug Distribution: Overview
Drug distribution within the body is a dynamic process involving the movement of a drug in two directions across various compartments: from the bloodstream into tissues (tissue uptake) and from tissues back into the bloodstream (tissue release or redistribution). This process is passive and primarily driven by two variables: the concentration gradient between the bloodstream and the extravascular tissues and the drug's ability to cross the cell membrane.
Initially, the free drug in the...
Initially, the free drug in the...
Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...


